|
Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025
|
|||||||||||
| Features of this market research: |
This report gives you the following benefits in particular: 121 seiten | |||||||||||
| About this market survey: |
Lyophilisation (also known as freeze drying or cryodesiccation) is an operation used for the preparation of stable pharmaceutical products. The market for lyophilisation has enjoyed strong growth in r.....
Lyophilisation (also known as freeze drying or cryodesiccation) is an operation used for the preparation of stable pharmaceutical products. The market for lyophilisation has enjoyed strong growth in recent years, driven by new products and drug classes, especially in biotechnology. In recent years, the number of such products has been growing steadily. It is predicted that half of the injectable drugs approved in the next five years will require lyophilisation. In our new report, we predict that the global lyophilisation market will grow steadily in revenue and unit sales from 2010 to 2025. Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 shows how the sector will be driven by the introduction of new products, particularly monoclonal antibodies (MAbs) and other proteins. There will also be developments in drying and packaging technologies. Products benefiting from lyophilisation technology include: • Active pharmaceutical ingredients (API) • Vaccines • Diagnostic kits • Reagents • Proteins • Hormones • Viral preparations • Bacterial preparations • Tissue preparations • Blood plasma products • Enzymes • Pathological samples • Nutraceuticals • Vitamins • Herbal extracts. There is an increased demand from pharmaceutical companies for manufacturing equipment and services for lyophilisation. As a result, the lyophilisation sector is one of the fastest growing in the global healthcare industry. All the therapeutic segments using lyophilisation have been expanding, but which will grow fastest in years to come? What are the main therapeutic and commercial trends to watch? How will the worldwide market for freeze-drying technology and services perform from 2010 to 2025? Our new report answers questions such as those, providing the information that you need. Our report shows how the lyophilisation market will experience strong revenue growth from 2010 to 2025, with greater demand for injectable drugs and vaccines requiring drying technologies. There are under-met needs for improved stability and cost effectiveness, as well as for more convenience in transport, storage and use of therapeutic agents. Rapid stabilisation, long-term product stability, ease of reconstitution and process advantages for heat-sensitive products will drive growth of the lyophilisation technology and services market. From 2010 onwards, there will be developments in freeze-drying technology that will benefit the sector and its customers, extending performance and applications. Detailed analysis of the lyophilisation industry and market Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 examines that sector through a comprehensive review of information sources, primary and secondary. This report provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are over 70 tables and figures included and an interview with an industry expert. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work. Report Highlights Companies Listed AAIPharma Services ABC Laboratories Allergan Almac Althea Technologies Azopharma Product Development Group Baxter Healthcare B. Braun Melsungen Ben Venue Laboratories Bilcare Global Clinical Supplies, Americas Biopharma Process Systems Biopharma Technology Cangene Biopharma Catalent Pharma Solutions CMC Biologics Coldstream Laboratories DSM Pharmaceuticals European Medicines Agency (EMEA) Food and Drug Administration (US FDA) Formatech Freezedry Specialties Fresenius Kabi Product Partnering FTS Systems Galenix GEA Lyophil (GEA Pharma Systems, GEA Group) Genentech Girindus America Gland Pharma GP Pharm Grand River Aseptic Pharmaceutical Packaging Haemtech Biopharma Services Haupt Pharma HollisterStier Contract Manufacturing Hospira One 2 One Hovione Huapont Pharm. Co. Hyaluron Contract Manufacturing (HCM) IDT Biologika IMA Edwards Pharmaceutical Systems Impact Analytical Intas Biopharmaceuticals Irvine Pharmaceutical Services JHP Pharmaceuticals Jouan Nordic KBI Biopharma King Pharmaceuticals KP Pharmaceutical Technology Lab. PiSA Labconco Corporation Lampire Biological Laboratories Legacy Pharmaceuticals International Lonza Lyophilisation Services of New England (LSNE) Lyophilisation Technology Martin Christ Gefriertrocknungsanlagen MedPharm Miltenyi Biotec, Bioprocess Division Ministry of Health, Labour and Welfare (Japan) Molecular Profiles National Archives and Records Administration (NARA), Document Conservation Laboratory (DCL) Nextar Chempharma Solutions (formerly Aminolab Pharma) NextPharma Nicholas Piramal Niro Nycomed Oakwood Laboratories OctoPlus Om Bhagwati Labelling Technologies Omnia Biologics One 2 One Global Pharmaceutical Services (Hospira) Optima Machinery Corporation Oregon Freeze Dry Oso BioPharmaceutical Manufacturing Overlook Industries Patheon Pfizer CentreSource Pharmatek Laboratories Piramal Healthcare PolyPeptide Laboratories Quality Assistance Rana Diagnostics Reig Jofré Group RFCL Richman Chemical Roche SAFC Pharma Sandoz (part of Novartis) Scripps Laboratories Serail Freeze-Drying Systems SL Pharma Labs Solvay SP Formulations SP Industries SRI International Stason Pharmaceuticals. Therapure Biopharma Thermo Fisher Scientific University of Iowa Pharmaceuticals (UIP) USIFROID Vectech Vetter Pharma International Vetter Pharma-Fertigung Walter Reed Pilot Bioproduction Facility [Fade out the market survey infos] |
|||||||||||
|
1. Executive Summary 1.1 Lyophilisation Market Review 1.2 Aims, Scope and Format of the Report 1.3 Research & Analysis Methods 2. Introduction to Lyophilisation (Freeze Drying) 2.1 Introduction 2.1.1 What is Freeze Drying? 2.1.2 Why Freeze Dry? 2.1.3 A Brief History 2.2 General Description of the Process 2.2.1 Freezing 2.2.2 Primary Drying (Sublimation) 2.2.3 Secondary Drying (Desorption) 2.2.4 Freeze Drying Equipment 2.2.4.1 Components of the Freeze Drier 2.2.4.1.1 Drying Chamber 2.2.4.1.2 Condenser 2.2.4.1.3 Vacuum Pump 2.2.4.1.4 Refrigeration System 2.2.4.1.5 Control Facilities 2.2.4.2 Rotary Freeze Dryers 2.2.4.3 Manifold Freeze Dryers 2.2.4.4 Tray Freeze Dryers 2.3 Applications of Lyophilisation 2.3.1 Pharmaceutical and Biotechnology Industry 2.3.2 Other Chemical and Technological Sectors 2.3.3 Veterinary Applications 2.3.4 Food Industry Applications 2.3.4.1 What Products are Freeze Dried? 2.3.4.2 How do Freeze Dryers for Food Differ from those for Pharmaceutical Applications? 2.3.5 Other Applications for Lyophilisation 3. Leading National Markets for Lyophilisation 3.1 The World Lyophilisation Technology Market in 2010 3.2 Growing Market for Lyophilisation Technology and Services 3.2.1 Sales Forecast for Overall Lyophilisation Market, 2010-2016 3.2.2 Sales Forecast for Overall Lyophilisation Market, 2017-2025 3.3 Breakdown of the Global Lyophilisation Market 3.3.1 Sales Forecast for cGMP Lyophilisers, 2010-2016 3.3.2 Sales Forecast for cGMP Lyophilisers, 2017-2025 3.3.3 Sales Forecast for Laboratory Lyophilisers, 2010-2016 3.3.4 Sales Forecast for Laboratory Lyophilisers, 2017-2025 3.3.5 Sales Forecast for Lyophilisation Services, 2010-2016 3.3.6 Sales Forecast for Lyophilisation Services, 2017-2025 3.4 Leading National Markets for Lyophilisation Technology, 2010-2025 3.4.1 Leading National Markets for Lyophilisation Technology, 2010-2025 3.4.2 The Japanese Lyophilisation Technology Market, 2010-2025 3.4.3 The Leading European Lyophilisation Technology Markets, 2010-2025 3.4.4 Emerging Economy Lyophilisation Technology Markets 3.4.5 The Chinese Lyophilisation Technology Market, 2010-2025 3.4.6 The Indian Lyophilisation Technology Market, 2010-2025 4. Worldwide Market for Lyophilised Products and Technology 4.1 Therapeutic Areas Offering Growth Opportunities 4.1.1 The Leading Biotech Therapy Classes, 2010-2025 4.1.2 The Top 10 Biotech Therapy Classes in 2009 4.1.3 The Oncology Class Currently Leads the Biotech Market 4.1.3.1 Long-Term Prospects in Oncology & Implications for Lyophilisation Market 4.1.4 The Human Insulins Class will Exhibit Strong Growth 4.1.5 Immunosuppressive Agents, 2010-2025 4.1.6 Autoimmune Agents Show Promising Growth - Will it Last? 4.1.7 Erythropoietin Products - How will Reported Safety Affect Sales? 4.1.7.1 Erythropoietin Products Forecast, 2010-2025 4.1.8 Immunostimulating Agents - Sales Prospects 4.1.9 The Interferons Class will Show an Increase in Revenues from 2010-2015 4.1.9.1 Long-Term Forecast for the Interferons Class 4.1.10 Will Pure Vaccine Sales Continue to Decline After 2015? 4.1.10.1 Will Pure Vaccines Sales Continue to Decline after 2015? 4.1.11 Blood Coagulation Factors will Show Steady Growth 4.1.12 Growth Hormones Forecast, 2010-2025 4.2 Summary of World Market Forecasts 4.2.1 The Top 10 Biotech Therapy Classes, 2010-2025 4.2.2 Lyophilisation Market: a Rapidly Expanding Segment of the Global Pharma Sector 5. Some Prominent Companies in the Lyophilisation Industry and Market 5.1 Introduction 5.2 GEA Lyophil 5.2.1 Overview 5.2.2 Capabilities of GEA Lyophil 5.2.3 Lyophilisation Production Systems 5.2.4 GEA Lyophil's Fast Track Project Management 5.2.5 GEA's Thermodynamic Lyophilisation Control 5.2.6 GEA's Retrofits of Lyophilisers 5.2.7 GEA's VAPOVAC: Technology for Freeze Dryer Sterilisation 5.2.8 GEA's Lyovac Production Lyophilisers 5.2.9 GEA Lyophil's Pilot Freeze Dryers 5.2.10 ALUS: GEA Lyophil's Automatic Loading and Unloading Systems for Lyophilisers 5.2.11 GEA Lyophil's Research and Development Freeze Dryers 5.3 Labconco Corporation 5.3.1 Overview 5.3.2 Global Presence 5.3.3 Product Focus 5.3.3.1 Freeze Dry Systems 5.3.3.2 Dry Ice Bench-top Freeze Dry System 5.3.3.3 FreeZone Bench-top Freeze Dry Systems 5.3.3.4 FreeZone Console Freeze Dry Systems 5.3.3.5 FreeZone Cascade Freeze Dry Systems 5.3.3.6 FreeZone Triad Freeze Dry Systems 5.3.4 Labconco Freeze Dry Accessories 5.3.5 R&D 5.3.6 Future Outlook 5.4 Vetter Pharma-Fertigung 5.4.1 Overview 5.4.2 Global Presence 5.4.3 Business Interests 5.4.3.1 Vetter Development Service 5.4.3.2 Vetter Commercial Manufacturing 5.4.3.3 Vetter Solutions 5.4.4 Capabilities 5.4.5 R&D 5.4.6 Product Focus 5.4.6.1 Dual-Chamber Technology 5.4.7 Future Outlook 5.5 Piramal Healthcare 5.5.1 Overview 5.5.2 Piramal's Corporate Restructuring 5.5.3 Therapeutic Interests 5.5.4 Global Presence 5.5.5 Strengths & Capabilities 6. SWOT Analysis of the Lyophilisation Technology Market 6.1 Introduction 6.2 Commercial Drivers of the Lyophilisation Technology Market 6.3 Commercial Restraints for the Lyophilisation Technology Market 6.3.1 High Entry Barriers to Sector 6.3.2 Product Formulation Challenges 6.3.3 R&D Stage for Lyophilised Products 6.3.4 Scale-up Stage for Lyophilised Products 6.3.5 Large Scale Production Stage for Lyophilised Products 6.3.6 Main Challenges in a Freeze-Drying Plant 6.3.7 Main Issues in Production 6.3.8 Typical Deficiencies in a Freeze-Drying Process 6.4 Challenges Facing the Lyophilisation Technology Industry and Market 6.4.1 Spray Drying of Biopharmaceuticals 6.4.2 Other Methods in Development 6.4.3 Roche's Precipitation Method 6.5 Expert Interview: Dr Steven Nail, Baxter Healthcare, USA 6.5.1 Current Market Worth for Freeze-drying 6.5.2 Products Suitable for Lyophilisation 6.5.3 Percentage of Lyophilised Products on Market 6.5.4 Key Areas for Research and Development 6.5.5 On Advantages of Lyophilisation 6.5.6 On Advantages of Lyophilisation over Other Drug Delivery Systems 6.5.7 On Drawbacks of Lyophilisation over Other Technologies 6.5.8 On Novel Technologies and Developments 6.6 Summary 7. Conclusions: Lyophilisation Technology and Services are a Growth Market 7.1 Overview 7.2 Prominent Companies in the Market 7.3 Commercial Drivers of the Lyophilisation Market 7.4 Future Outlook and Concluding Remarks [Fade out table of contents] |
||||||||||||
|
Table 3.1 Lyophilisation Technology and Services: World Sales Forecast, 2010-2016 Table 3.2 Lyophilisation Technology and Services: World Sales Forecast, 2017-2025 Table 3.3 cGMP Lyophilisers: World Sales Forecast, 2010-2016 Table 3.4 cGMP Lyophilisers: World Sales Forecast, 2017-2025 Table 3.5 Laboratory Lyophilisers: World Sales Forecast, 2010-2016 Table 3.6 Laboratory Lyophilisers: World Sales Forecast, 2017-2025 Table 3.7 Lyophilisation Services Market: World Sales Forecast, 2010-2016 Table 3.8 Lyophilisation Services Market: World Sales Forecast, 2017-2025 Table 3.9 Lyophilisation Market: World Sales Forecast, 2010-2016 Table 3.10 Lyophilisation Market: World Sales Forecast, 2017-2025 Table 3.11 Leading Lyophilisation National Market Forecasts, 2010-2015, 2020 & 2025 Table 4.1 The Top 10 Biotech Therapy Classes, 2009 Table 4.2 Oncology Class: World Sales Forecast, 2010-2016 Table 4.3 Oncology Class: World Sales Forecast, 2017-2025 Table 4.4 Human Insulins Class: World Sales Forecast, 2010-2016 Table 4.5 Human Insulins Class: World Sales Forecast, 2017-2025 Table 4.6 Immunosuppressive Agents Class: World Sales Forecast, 2010-2016 Table 4.7 Immunosuppressive Agents Class: World Sales Forecast, 2017-2025 Table 4.8 Autoimmune Agents Class: World Sales Forecast, 2010-2016 Table 4.9 Autoimmune Agents Class: World Sales Forecast, 2017-2025 Table 4.10 Erythropoietin Products Class: World Sales Forecast, 2010-2016 Table 4.11 Erythropoietin Products Class: World Sales Forecast, 2017-2025 Table 4.12 Immunostimulating Agents Class: World Sales Forecast, 2010-2016 Table 4.13 Immunostimulating Agents Class: World Sales Forecast, 2017-2025 Table 4.14 Interferons Class: World Sales Forecast, 2010-2016 Table 4.15 Interferons Class: World Sales Forecast, 2017-2025 Table 4.16 Pure Vaccines Class: World Sales Forecast, 2010-2016 Table 4.17 Pure Vaccines Class: World Sales Forecast, 2017-2025 Table 4.18 Blood Coagulation Factors Class: World Sales Forecast, 2010-2016 Table 4.19 Blood Coagulation Factors Class: World Sales Forecast, 2017-2025 Table 4.20 Growth Hormones Class: World Sales Forecast, 2010-2016 Table 4.21 Growth Hormones Class: World Sales Forecast, 2017-2025 Table 4.22 Leading Biotech Therapy Classes: World Sales Forecasts, 2010-2016 Table 4.23 Leading Biotech Therapy Classes: World Sales Forecasts, 2017-2025 Table 5.1 GEA Pharma Systems: A Historical Perspective Table 5.2 Labconco: A Brief History Table 5.3 Leading Companies in the Lyophilisation Market, 2010 Table 6.1 SWOT Analysis for the Lyophilisation Sector: Strengths and Weaknesses, 2010-2025 Table 6.2 SWOT Analysis for the Lyophilisation Sector: Opportunities and Threats, 2010-2025 Table 6.3 Advantages of a Spray Dryer for Drying Applications, 2010 Table 6.4 Comparison of Lyophilisation and Spray Drying, 2010 Table 7.1 Lyophilisation Market: World Sales Forecast, 2010, 2012, 2015, 2018, 2020 and 2025 Figure 2.1 The Freeze Drying Process Figure 2.2 Components of a Typical Freeze Dryer Figure 2.3 Typical Lyophilisation (Freeze Drying) Process Figure 3.1 Lyophilisation Technology and Services: World Sales Forecast, 2010-2016 Figure 3.2 Lyophilisation Technology and Services: World Sales Forecast, 2017-2025 Figure 3.3 cGMP Lyophilisers: World Sales Forecast, 2010-2016 Figure 3.4 cGMP Lyophilisers: World Sales Forecast, 2017-2025 Figure 3.5 Laboratory Lyophilisers: World Sales Forecast, 2010-2016 Figure 3.6 Laboratory Lyophilisers: World Sales Forecast, 2017-2025 Figure 3.7 Lyophilisation Services Market: World Sales Forecast, 2010-2016 Figure 3.8 Lyophilisation Services Market: World Sales Forecast, 2017-2025 Figure 3.9 Lyophilisation Market: World Sales Forecast, 2010-2025 Figure 3.10 US Lyophilisation Market: Sales Forecast, 2010-2025 Figure 3.11 Other Leading Lyophilisation National Markets: Sales Forecasts, 2010-2025 Figure 3.12 Lyophilisation Sales Shares in Leading National Markets, 2010 Figure 3.13 Lyophilisation Sales Shares in Leading National Markets, 2015 Figure 3.14 Lyophilisation Sales Shares in Leading National Markets, 2020 Figure 3.15 Lyophilisation Sales Shares in Leading National Markets, 2025 Figure 4.1 Oncology Class: World Sales Forecast, 2010-2025 Figure 4.2 Human Insulins Class: World Sales Forecast, 2010-2025 Figure 4.3 Immunosuppressive Agents Class: World Sales Forecast, 2010-2025 Figure 4.4 Autoimmune Agents Class: World Sales Forecast, 2010-2025 Figure 4.5 Erythropoietin Products Class: World Sales Forecast, 2010-2025 Figure 4.6 Immunostimulating Agents Class: World Sales Forecast, 2010-2025 Figure 4.7 Interferons Class: World Sales Forecast, 2010-2025 Figure 4.8 Pure Vaccines Class: World Sales Forecast, 2010-2025 Figure 4.9 Blood Coagulation Factors Class: World Sales Forecast, 2010-2025 Figure 4.10 Growth Hormones Class: World Sales Forecast, 2010-2025 Figure 4.11 Leading Biotech Therapy Classes: World Sales Forecast, 2010-2025 Figure 4.12 Top Ten Therapy Classes: World Sales, 2009, 2015 & 2025 Figure 7.1 Lyophilisation Market: World Sales Forecast, 2010-2025 [Fade out list of tables / figures] |
||||||||||||
| Price ** (Report format): |
free of shipping costs ** IMPORTANT: All prices are net prices without taxes. Depending on the country in your billing address you have to pay sales taxes. If you have given us your billing adress, VAT No., etc. the correct total amount will be stated in the following order process. More informations on prices and taxes please find in our FAQs. |
|||||||||||
| Notice for this market research report: | * The invoice amount for this study is accounted in $ (dollar). Your bank or your credit card supplier will calculate the topical day course in your currency to you on payment. | |||||||||||
